<DOC>
	<DOCNO>NCT00523614</DOCNO>
	<brief_summary>The objective study compare risk venous thromboembolism ( VTE ) oral contraceptive non-use , focus specifically ValetteÂ® compare user low estrogen dose combine oral contraceptive .</brief_summary>
	<brief_title>Use Oral Contraceptives ( OCs ) Containing Dienogest Risk Venous Thromboembolism</brief_title>
	<detailed_description>This population-based case-control study Germany . Cases woman 15 49 year old diagnosis venous thromboembolism ( VTE ) . The VTE diagnose Germany January 2002 und December 2007 . Controls woman 15 49 year old without VTE diagnosis . About 4 control match year birth region allocate case . Both case control receive similar self-administered questionnaire except case-specific question applicable control . Study participant ask informed consent . Data confidentiality ensure Berlin Center Epidemiology Health Research .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<criteria>case : woman venous thromboembolism 15 49 year old control : woman without venous thromboembolism diagnosis 15 49 year old woman outside define age range woman severe language problem woman willing participate</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>venous thromboembolism</keyword>
</DOC>